Sands Capital Life Sciences Pulse Fund II, L.P.

Inhibikase Therapeutics, Inc. · 10% Owner

Sands Capital Life Sciences Pulse Fund II, L.P. is listed in public filings as 10 percent owner. This Sands Capital Life Sciences Pulse Fund II, L.P. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Inhibikase Therapeutics, Inc. (IKT). Investors use Sands Capital Life Sciences Pulse Fund II, L.P.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Inhibikase Therapeutics, Inc.IKT$3.0M2.1M sharesBuyNov 21, 2025$1.45--